Published Date:2023-04-28 Original Link:https://www.onenessbio.com/en/news_detail225_4.htm No 1 Date of announcement 2023/04/28 Time of announcement 22:12:32 Subject Announcement of the Phase 1 clinical trial data of SNS812, a broad-spectrum antiviral siRNA for COVID-19 developed jointly by Oneness and Microbio (Shanghai) Co.,Ltd. To which item it meets paragraph 10 Date of events 2023/04/28 Statement Product:SNS812, a broad-spectrum siRNA...Read More